Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Big Lots, Inc. (BIG): This Closeout Retailer Is a Good Buy

Page 1 of 2

Since the beginning of the year, Big Lots, Inc. (NYSE:BIG) has been quite volatile. The company’s stock had surged from around $28.50 per share to nearly $38.80 per share in the middle of May, and then dropped to around $33.80 per share at the time of writing. Famous investors such as Joel Greenblatt, Richard Snow and Ray Dalio have Big Lots in their portfolios. Should investors follow these successful investors into Big Lots? Let’s find out.

Big Lots, Inc.

Consistent share buybacks

Big Lots, Inc. (NYSE:BIG) is considered to the biggest broadline closeout retailer, operating 1,574 stores in the U.S. and Canada. The company sources closeout merchandise at lower costs, offering it to customers at lower prices than those of traditional discount retailers. In the past five years, Big Lots has consistent grown its number of stores from 1,339 in 2008 to 1,574 in 2012. During that time period, Big Lots has also consistently produced positive net income, fluctuating in the range of $152 million to $223 million. The company’s earnings-per-share has kept rising in the past five years as well, mainly due to consistent share buybacks. The share count has been reduced from 82 million in 2008 to only 59 million in the first quarter 2013.

Lower guidance but cheaply valued

In the first quarter 2013, Big Lots, Inc. (NYSE:BIG) experienced a drop of 2.9% in its comparable same-store sales. Its net income decreased more than 20.6%, from $40.75 million in the first quarter last year to $32.33 million this year. The company’s earnings-per-share came in at $0.56, 12.5% lower than the earnings-per-share of $0.64 that it reported last year. The company also lowered its earnings guidance for the full year. It expected net sales to rise by 1%-2%, while the adjusted non-GAAP consolidated income from continuing operations was estimated to be in the range of $2.87 to $3.12 per share. Big Lots is trading at $33.80 per share, with the total market cap of around $1.9 billion. The market values Big Lots at only 5 times its trailing EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization).

Dollar General Corp. (NYSE:DG) & Target Corporation (NYSE:TGT) – lower ROIC but higher valuation

Compared to its larger peers, such as Dollar General and Target, Big Lots, Inc. (NYSE:BIG) seems to be quite cheaply priced.

Dollar General is currently trading at $51.10 per share, with the total market cap of $16.7 billion. The market values Dollar General at 9.8 times its trailing EBITDA. For the full year 2013, Dollar General Corp. (NYSE:DG) expected its year-over-year sales growth to stay around 10%-11% with the same store sales growth of 4%-5%. The diluted earnings-per-share, excluding note refinancing charges or secondary stock offerings expenses, was estimated to be in the range of $3.15 to $3.22 per share.

Target Corporation (NYSE:TGT) is also more expensively valued on the market than Big Lots, Inc. (NYSE:BIG). At $70 per share, Target is worth around $44.90 billion, with the market valuing it at 7.4 times its trailing EBITDA. In the first quarter 2013, Target experienced a decline in both its top line and its bottom line. While revenue decreased from $16.87 billion last year to $16.7 billion this year, its net income dropped by 28.5% to only $498 million or $0.77 per share. Target has returned cash to it shareholders via both dividend payments of $232 million and share buybacks of $547 million, however. For the full year, Target expected that its earnings-per-share would be in the range of $4.12 to $4.32.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!